Findings demonstrate ATYR2810’s anti-tumor activity and increased survival in a model of glioblastoma multiforme (GBM), a ...

Puma Biotechnology announced Phase I data of trastuzumab deruxtecan plus neratinib in solid tumors with HER2 alterations was ...

Commissioners visit UD-based NIIMBL, where public-private partnerships promote innovation, workforce development ...

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

Exosome-Based ExoPTEN Targets Three High-Value Nerve Injury Indications. TORONTO and HAIFA, Israel, April 24, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: N ...

Transgene Provides Business and Financial Update for Q1 2025  TG4050: Updated randomized Phase I data to be presented in Rapid Oral Presentation at ASCO 2025Dr. Simone Steiner appointed Chief ...

PITTSBURGH, April 24, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company”) (NASDAQ: KRYS) announced today that the Company will be presenting on multiple programs in the lung, eye, and skin ...

PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...

ORIC Pharmaceuticals has promising early data for ORIC-944 and ORIC-114, but remains in very early clinical stages. See why I ...

AAAS Student E-poster Competition Winners. The AAAS Student E-poster competition recognizes the individual efforts of students who are actively working toward an undergraduat ...

Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viruses, ...